Compendium

Surgical Robotics — Robotics Reference (expanded 2026-05-17)

21 min read

Surgical Robotics — Robotics Reference (expanded 2026-05-17)

1. At a glance

Surgical robotics enhances surgeon dexterity, visualization, reach, and precision beyond what unaided hands and conventional laparoscopic shafts can achieve. The modern era began with Intuitive Surgical’s da Vinci (FDA cleared 2000) and ISS/Computer Motion ZEUS (merged into Intuitive 2003); cumulative deployment has now passed ~10 million robotic procedures globally with da Vinci alone running ~2.0 million procedures in 2024 (Intuitive Surgical 10-K 2024) across an installed base exceeding 9,900 systems. The global surgical-robotics market is in the USD 8-12 B/yr range as of 2024-25 and is growing at a 15-25%/yr CAGR depending on segment.

Demand drivers are structural and long-running:

  • Aging population with rising prevalence of cancer, joint degeneration, valvular and arrhythmia disease, and degenerative spine pathology.
  • Minimally invasive surgery (MIS) demand — patients and payers favor smaller incisions, shorter length-of-stay, and faster return-to-work.
  • AI and image-guidance maturation — surgical-phase recognition, anatomy segmentation, AR overlays, and outcome analytics now layered on top of robotic platforms.
  • Surgeon ergonomics — open and laparoscopic surgery have measurable musculoskeletal injury rates; consoles eliminate static loaded posture.
  • Emerging-market indigenous platforms (China, India, Russia) finally serializing in 2023-25, expanding access at lower price points.

Surgical robotics is therefore both a mature commodity (laparoscopic teleoperation) and a frontier field (autonomy, microsurgery, magnetic-steering, 5G tele-surgery).

2. Major commercial systems by modality

2.1 Laparoscopic / general soft-tissue

  • Intuitive Surgical da Vinci — flagship of the field. Variants: Xi (4-arm 2014), X (cost-reduced 2017), SP (single-port through one 25 mm cannula, FDA 2018 urology then 2022-24 expansions to TORS/colorectal), and Series 5 (next-gen system launched H2 2024 with force-sensing instruments, 10,000 force-monitoring points, integrated digital case-mgmt, improved energy delivery). Installed base ~10,000 globally; instrument lifecycle ~10 uses enforced by RFID-keyed counter on EndoWrist.
  • Medtronic Hugo RAS — modular cart-based 4-arm system, CE Mark 2021, multi-country commercialization 2022-24, FDA IDE EXPAND URO trial completed; US 510(k)/De Novo clearance achieved 2024-25 for urology/gyn. Differentiates on open architecture, force feedback, video streaming via Touch Surgery Enterprise.
  • CMR Surgical Versius — UK/EU/India commercial since 2019; small modular arms (each a separate cart), wristed 5 mm instruments, surgeon console with open-display + 3D glasses. Strong UK NHS and India deployment.
  • Asensus Senhance (formerly TransEnterix) — FDA 2017; reusable 3-5 mm instruments, eye-tracking camera control, haptic feedback, ML overlay (“Intelligent Surgical Unit”). Acquired by KARL STORZ 2024-25 to merge with the Image1S/VISERA ecosystem.
  • Distalmotion Dexter — Swiss start-up, CE 2021; hybrid robot (surgeon stays sterile next to bedside, switches between manual lap and console). Strong EU adoption in urology.
  • Medical Microinstruments (MMI) Symani — sub-millimeter teleoperated microsurgery (see §2.7).
  • Avatera Medical (Germany) — CE-marked, serving China + Russia + India. Edge Medical MP1000 (Shenzhen) — NMPA approved 2023, several thousand procedures across Tongji and partner hospitals.
  • SS Innovations SSi Mantra (India) — CDSCO approved 2022, commercial 2023, lowest-cost teleoperated platform globally (~USD 0.7-1.0 M vs ~2-2.5 M for da Vinci Xi).
  • Medicaroid Hinotori (Japan, Kawasaki/Sysmex JV) — PMDA 2020 for urology, 2022-24 expansions to GI/gyn.

2.2 Orthopedic + spine

  • Stryker Mako — acquired 2013 from MAKO Surgical (originally RIO). Indications: knee (TKA + UKA), total hip, spine (Mako Spine launched 2024). Installed base >1,500 systems globally; >1 M procedures cumulative. Robotic arm provides haptic boundary control during bone cuts and impaction (cannot cross planned envelope).
  • Smith+Nephew CORI — handheld active robot (no patient-side cart), saw mounted to surgeon’s hand with infrared tracking and automatic blade retraction inside safe zone. TKA/UKA/PKA.
  • Zimmer Biomet ROSA — Knee, Hip, Brain (neurosurg), Spine. Acquired Medtech SA 2016. ROSA Knee FDA 2019, ROSA Hip 2021.
  • Medtronic Mazor X Stealth + StealthStation S8 — spine pedicle-screw planning + execution; Mazor acquired 2018. >500,000 screws placed cumulatively, accuracy 98%+ vs freehand 90-92%.
  • Globus Medical ExcelsiusGPS / ExcelsiusFlex / ExcelsiusHub — robot + nav + intra-op imaging combined platform. Merged with NuVasive 2023 (“Globus + NuVasive” — now world’s #2 spine company by revenue).
  • Auris Monarch — bronchoscopy + planned urology (see §2.5); acquired by Johnson & Johnson MedTech 2019 for USD 5.75 B; merged with Verb Surgical’s IP under “Ottava” platform (J&J’s lap robot in IDE trials 2024-25).
  • Brainlab Cirq — modular robotic arm for cranial, spine, orthopedic; integrates with Brainlab Loop-X intra-op CT and Curve Navigation.
  • THINK Surgical TMINI — handheld active milling robot for TKA; expanded indication clearance Mar 2025 (added cementless components + revisions).
  • MicroSure MUSA + MMI Symani for reconstructive/microsurgical anastomosis (see §2.7).

2.3 Neurosurgery

  • Medtronic Stealth + O-arm + Mazor X Stealth — combined cranial/spine platform.
  • Globus ExcelsiusGPS Cranial — single-arm cranial registration + stereotactic navigation.
  • Brainlab Cirq + Cranial — robotic arm with image-guided cranial trajectories (biopsy, DBS lead placement, SEEG).
  • Synaptive Modus V — robotic exoscope + BrightMatter planning, replacing operating microscope; commercial since 2018 across NA + EU.
  • Renishaw NeuroMate — functional neurosurgery (DBS, SEEG, stereotactic biopsy); installed >300 sites; UK MHRA + FDA cleared.
  • KARL STORZ exoscope (VITOM 3D) + Synaptive Modus V + Olympus ORBEYE — robotic exoscope alternatives to operating microscope.
  • 7D Surgical Machine-Vision Image-Guided Surgery (MvIGS) — image-based registration without intra-op CT/fluoro; acquired by SeaSpine 2021 → Orthofix 2023 (merger) → operates as Orthofix Global Surgical → segments sold to Renishaw 2024-25.

2.4 Cardiovascular

  • Robocath R-One / R-Two — PCI (percutaneous coronary intervention) robot; CE 2019; first US clinical use 2024 under early-feasibility study; tele-PCI demos across France 2023-24.
  • Microbot Liberty — single-use peripheral/neurovascular endovascular robot; FDA pivotal trial 2024-25.
  • Siemens Healthineers (Corindus) CorPath GRX — acquired Corindus 2019; GRX line discontinued 2024 and relaunched as Cor-Path Vascular Robotic System with improved guide-catheter/guidewire/balloon manipulation and PCI + neurovascular indications.
  • Stereotaxis Niobe ES + Genesis RMN — magnetic-steering platform for cardiac electrophysiology ablation (see §12); MAGIC ablation catheter (Stereotaxis × Osypka) CE Mark 2024, FDA submission 2025.
  • Stereotaxis Synchrony — software platform integrating RMN with EP mapping (CARTO, Rhythmia, EnSite).
  • Asahi Intecc / Terumo / Boston Scientific — guidewires, catheters, embolic devices upstream of robotic platforms.
  • Endotronix Cordella + Edwards Sapien + Abbott TriClip — robotic-assist for structural-heart procedures emerging 2024-25.

2.5 Pulmonology / ENT / airway

  • Auris/J&J Monarch Platform — robotic bronchoscopy for peripheral lung-nodule biopsy + planned urology (stone management). FDA 2018; >30,000 procedures cumulative.
  • Intuitive Ion — single-use catheter inside a robotic platform with shape-sensing fiber (FBG-based) for ultrathin peripheral access; FDA 2019; commercial 2020+. >100,000 procedures by 2024.
  • Galen Surgical — ENT (otologic, sinus) precision tools.
  • Penumbra Indigo / Magellan — peripheral vascular thrombectomy + endovascular robotics.

2.6 Ophthalmic

  • Preceyes Surgical System (Netherlands, spun from TU Eindhoven, acquired by Zeiss 2022) — sub-retinal injection robot for gene-therapy delivery (Spark/Roche Luxturna RPE65 + emerging gene therapies); RIDR (Robotic Intraocular Drug Delivery) clinical use.
  • Robot-assisted PRK / LASIK + femto-laser — Bausch+Lomb Stellaris + Zeiss VisuMax 800 (femto-laser refractive 2023-24) + Schwind Atos + Alcon LenSx. Not “robots” in the manipulator sense but autonomous-trajectory laser systems with eye-tracking.
  • Acumen Bioscience — early-stage robotic ophthalmic platform.
  • iRobotic ophthalmic + Forsight Robotics ORYOM — research stages, animal/human first-in-man 2024-25.

2.7 Microsurgery / supermicrosurgery

  • MMI Symani Surgical System (Calci, Italy) — teleoperated micro-instruments (NanoWrist) for sub-1 mm anastomosis in lymphatic, reconstructive, peripheral nerve work. CE 2019; US FDA De Novo 2024; >5,000 procedures cumulative. Native force feedback at the instrument tip is a differentiator vs da Vinci.
  • MicroSure MUSA + MUSA-2 / MUSA-3 (Netherlands, spun from Eindhoven Maastricht) — robotic microsurgery for lymphatico-venous anastomosis (LVA). CE 2019; commercial in EU 2020+.
  • Maestro / Estrosur — research platforms from Imperial Hamlyn / Strasbourg IRCAD.

2.8 Capsule endoscopy + flexible / magnetic catheters

  • Medtronic PillCam (SB3, COLON2, Crohn’s) + Olympus EndoCapsule EC-10 + CapsoVision CapsoCam + Ankon NaviCam Capsule + Anx Robotica NaviCam — magnetic-driven steerable capsule endoscopes for esophageal / gastric / SB / colonic surveillance. NaviCam uses an external magnetic-field robot to steer the capsule in the stomach.
  • Soft + magnetic catheters for GI and cardiovascular (also covered in [[Robotics/soft-robotics]]).

2.9 Dental

  • Neocis Yomi — FDA cleared 2017 for dental-implant placement; >1,000 implants in 2024 alone; integrates pre-op CBCT planning with intra-op haptic guidance; only FDA-cleared dental implant robot in US.
  • DentalRobotPro + Bear Robotics (Korea) — emerging platforms; Beijing Stomatological Hospital reported world’s first fully autonomous robotic dental implant 2017, now in clinical use.

3. Generic surgical-robot architecture

A clinical lap robot (the archetype) comprises:

  • Patient-side cart — 2-4 manipulator arms, each 5-6 DoF + instrument shaft + 3-DoF wrist + 1-DoF jaw (total 7-9 DoF). One arm carries a 3D HD endoscope.
  • Surgeon console — immersive stereo 3D display (binocular HMD-like with 1080p or 4K per eye), pair of master controllers (6-DoF haptic + pinch grip), foot pedals (camera, energy, clutch, focus), microphone, eye-tracker, ergonomic adjustable chair.
  • Vision tower — light source (xenon or LED), insufflator (CO2 up to 15 mmHg), camera control unit, electrosurgery generator (mono + bipolar + ultrasonic + advanced energy like Harmonic + Ligasure + EndoWrist Vessel Sealer), suction-irrigation pump, surgical recorder (Touch Surgery Enterprise / Caresyntax / Theator).
  • Instrument cart + sterile reprocessing — EndoWrist trays, sterile drapes, accessories.
  • Network — internal Ethernet + CAN/EtherCAT real-time bus; optical fiber for video; isolated medical-grade isolation transformer + UPS for power; cybersecurity per FDA 524B (2023).

Orthopedic and neurosurgical systems differ — bone is fixed in space, so RCM is irrelevant; instead, rigid registration of pre-op CT/MRI to intra-op anatomy is the central problem.

4. Surgeon console + master controllers

Master devices translate hand-grip motion to instrument-tip motion. Historical research used Sensable Phantom Omni / Geomagic Touch X (3-DoF + stylus); production consoles use custom 6-DoF haptics with finger-pinch grippers (the da Vinci master mimics the EndoWrist).

Force feedback is contested:

  • da Vinci — minimal haptic feedback historically; Intuitive’s position is that 3D vision compensates and “visual force feedback” via tissue blanching/deformation suffices for expert hands. Series 5 (2024) adds Force Feedback for the first time across major instruments.
  • Hugo / Versius / Senhance / Symani / MUSA all feature genuine proximal or distal force sensing with bilateral feedback.

Stereo display: 1080p per eye on da Vinci Xi → 4K on Series 5 with optional 8K endoscope announced 2024. Eye-tracker for auto-camera-control + safety interlock (release masters if eyes leave display).

5. Patient-side arm + Remote Center of Motion (RCM)

The defining mechanical constraint of laparoscopic robotics is the trocar port — the instrument shaft must pivot about the body-wall puncture without applying lateral force. Two classical solutions:

  • Cardan / parallelogram passive RCM — the kinematic chain mechanically constrains pivot at a fixed point in space (Hannaford 1992, Stoianovici 1998 isocentric mechanism). No software constraint required; safe under power loss.
  • Active software RCM — general 7-DoF arm with redundancy + algorithmic constraint maintaining virtual fulcrum (CMR Versius, Hugo).

Once RCM is set, 4 useful DoF survive for the surgeon: insertion depth, two pitch/yaw rotations about the port, and roll about the shaft. The instrument wrist (3 DoF) + jaw (1 DoF) gives total 7-9 DoF per arm — exceeding the rigid laparoscope’s 4 DoF (no wrist), which is the dexterity argument for robotic MIS.

6. Instruments + EndoWrist

(Wrist design details: [[Walkthroughs/design-surgical-robot-wrist]].) Shafts are typically 8 mm or 5 mm outer diameter; jaw lengths 10-25 mm. Instrument families: harmonic-shears, Maryland bipolar forceps, needle-driver, grasper, Cadiere forceps, hook electrode, scissors, Vessel Sealer, Stapler 30/45/60 mm. Materials per [[Engineering/Tier3/stainless-steels]] — 17-4 PH for structural shafts, 316L / 304 for cannulas and outer sleeves, with TiN PVD coating ([[Engineering/Tier3/surface-treatments]]) for grippers.

Lifecycle: reusable for ~10-15 autoclave cycles (134 °C, 4.5 bar, 18 min) tracked via RFID-keyed counter on the instrument hub (Intuitive’s “10-life” model).

7. Vision + AR / MR

  • Stereo HD endoscope — 3D 1080p per eye on Xi; 4K on Series 5; 8K announced 2024.
  • Fluorescence imaging — Indocyanine Green (ICG) excited at 805 nm, emits 830 nm. Intuitive Firefly (now standard on Xi/X/Series 5); Medtronic GreenLight; Olympus VISERA ELITE III. Used for perfusion (anastomotic leak prediction), lymph-node mapping, biliary anatomy, ureter visualization.
  • AR overlay of pre-op CT/MRI on the surgical view — Brainlab Cirq + Curve, Synaptive Modus V, Augmedics xVision (head-mounted AR for spine pedicle-screw placement, FDA 2020, expanded indications 2023-24), Microsoft HoloLens 2 with custom apps for spine and cranial.
  • Intuitive da Vinci Iris — intra-operative imaging integration announced 2024 (CT-to-console overlay for partial nephrectomy).
  • Surgical AI overlay — Activ Surgical ActivSight (ICG + perfusion + AI on standard endoscope), Theator + Caresyntax for video analytics, Procept BioRobotics AquaBeam for prostate water-jet ablation with image-guided trajectory.

8. Bilateral teleoperation + scaling

Master-slave mapping uses Cartesian position/orientation scaling typically 3:1 to 5:1 (hand moves 3-5 cm, instrument tip moves 1 cm). This both increases precision and amplifies workspace coverage.

  • Tremor filter — physiological hand tremor is 8-12 Hz; low-pass filtering below ~6 Hz removes it without affecting voluntary motion.
  • Latency budget — < 200 ms one-way for human surgical perception of “transparency” (Kontravdis et al. 1999). > 300 ms degrades performance noticeably; > 500 ms is unsafe for fine work without supervisory control.
  • Long-distance tele-surgery — first transatlantic Lindbergh Operation 2001 (Marescaux, NYC → Strasbourg cholecystectomy on porcine then human, ZEUS robot, dedicated ~155 ms fiber). 2024-25 5G demonstrations: Tianjin → Beijing (>800 km, ~30 ms latency) cholecystectomy and partial nephrectomy on porcine + select human cases; ongoing China + EU + India trials.

Long-distance work requires bidirectional encryption + auth (per FDA 524B 2023 + EU MDR/IEC 81001-5-1 cybersecurity) and fail-safe behaviors (instrument retracts to RCM on link loss).

9. Force + tactile feedback

The “haptic gap” of early da Vinci was contested. Newer architectures aim for bilateral transparency:

  • Proximal force sensing — load cells at the instrument hub estimate tip force after dynamic-model compensation. Cheaper, lower fidelity.
  • Distal force sensing — strain gauges or fiber-Bragg-grating (FBG) optical sensors at the wrist or jaw, directly measuring tip force/torque. Higher fidelity but cost + sterilization-survival challenge. Series 5 + Symani + Senhance use variants of distal sensing.
  • Impedance shaping — virtual fixtures (haptic guidance) and active boundary control (Mako) constrain the surgeon’s motion within planned envelopes.

10. AI in surgical robotics

The AI layer has matured from research demos to commercial decision-support overlays between 2020 and 2025.

  • Automated technical-skill assessment — OSATS-style scoring via kinematic + endoscopic-video features. Used in training (Mimic, FundamentalVR, Osso VR + Intuitive SimNow).
  • Surgical-phase recognition — temporal CNN + transformer on endoscope video labels procedure phase (“dissection”, “clipping”, “transection”) in real time. Theator, Caresyntax, Activ Surgical, Surgical Theater, Touch Surgery (Medtronic). Roots in UCL, Strasbourg IRCAD, Intuitive research.
  • Anatomy recognition + semantic segmentation — vessels, ureters, bile duct, nerve, tumor; Imperial Hamlyn Centre, Asensus Senhance Intelligent Surgical Unit.
  • Skill coaching + retrospective analysis — Proximie, Activ Surgical, Theator; replay video with AI-marked anatomy + critical-view checks (e.g. Critical View of Safety for cholecystectomy).
  • Anomaly + adverse-event detection in real time (bleeding, off-target dissection).
  • Partial autonomy + Smart Tissue Autonomous Robot (STAR) — Krieger Lab + Children’s National + Johns Hopkins; 2022 Sci Robot paper (Saeidi et al.) demonstrated autonomous intestinal anastomosis on live porcine tissue, performed entirely by the robot (suturing + knot-tying). 2023-25 work extended to vascular anastomosis and tumor-margin resection in animal trials.
  • Foundation models for surgery (RAS-LLM / SurgLM) — emerging 2024-25 from Hamlyn, Strasbourg, Intuitive AI, Caresyntax, and OpenAI/Google collaborations; large vision-language models pretrained on surgical video that can perform phase recognition, anatomy QA, anomaly flagging, and post-op narrative generation.
  • Augmented-reality + image-guided — covered §7.

(Foundation-model background: [[Compute/transformer-architecture]].)

11. Specialty: orthopedic robotics + bone milling

Bone is rigid and registrable, which makes ortho the easiest target for active and shared-control robotics.

  • Stryker Mako — surgeon holds a saw or bur mounted on the robot’s tool flange; the robot does not move autonomously, but applies haptic resistance when the tool approaches the planned envelope boundary. Surgeon retains motion authority; robot bounds it. Pre-op CT → planning → intra-op registration via percutaneous pins + array (mismatch tolerance < 1 mm verified pre-cut).
  • Smith+Nephew CORI — handheld active saw, automatic blade retraction inside safe zone (no haptic arm); image-free registration via bone-surface mapping.
  • THINK Surgical TMINI — handheld milling spindle, similar concept to CORI but with cutter-burn-rate control via servo loop.

Bone-milling forces are an order of magnitude higher than soft-tissue dissection; ortho arms have higher stiffness, larger gearheads, more conservative current limits. Because bone is fixed (clamped in a leg holder or rigidly tracked), there is no need for RCM-style port constraints.

(Biomechanics + bone-cutting context: [[Engineering/biomechanics]].)

12. Specialty: cardiac EP + magnetic steering

Stereotaxis Genesis RMN (Robotic Magnetic Navigation) places two large permanent magnets on robotic arms around the patient; rotating them creates a steerable magnetic field that bends the magnetic-tip ablation catheter inside the chambers of the heart. Advantages:

  • Atraumatic navigation — catheter is soft, body bends to the field rather than being pushed.
  • Reduced fluoroscopy — operator works from a remote workstation, radiation dose to patient + staff down 70-90%.
  • Access — pediatric + complex congenital + AF + VT ablation in patients where manual catheter handling is impossible.

MAGIC catheter (Stereotaxis × Osypka) — open-irrigated, contact-force-sensing, fully integrated with Synchrony mapping integration to CARTO / EnSite. CE 2024, FDA submission 2025.

13. Specialty: lung biopsy bronchoscopy

Small peripheral lung nodules (<2 cm) historically had poor diagnostic yield on bronchoscopy (40-50%). Robotic bronchoscopy uses a flexible catheter with electromagnetic navigation + 3D-reconstructed CT to reach lesions with 70-85% diagnostic yield in current series (Chen et al. 2024).

  • Auris Monarch (J&J) — dual-telescoping catheter (outer sheath 6.0 mm + inner 4.4 mm) for stability + reach.
  • Intuitive Ion — single-use catheter (3.5 mm OD) with shape-sensing fiber (FBG) along the entire length, giving real-time tip pose without continuous fluoroscopy.

Combined with cone-beam CT in hybrid suites + electromagnetic navigation (ENB) + radial-probe endobronchial ultrasound, peripheral diagnostic accuracy continues to climb. 2024 outcome registries (PRECIsE, BENEFIT) show non-inferiority to transthoracic biopsy with substantially lower pneumothorax rates.

14. Sterilization + reprocessing + supply chain

  • Steam autoclave — 134 °C, 4.5 bar, 18 min cycle is the dominant pathway; instruments must survive 10-15 cycles minimum. Hub electronics potted in PEEK + silicone-rubber to survive thermal cycling.
  • Single-use sterile-pack alternative — Intuitive Ion catheter, MMI NanoWrist (some indications), Microbot Liberty are single-use.
  • EtO sterilization for heat-sensitive electronics; long aeration cycle limits throughput.
  • Cold-chain not generally required — robotic instruments are mechanical/electronic, not biologic. Exception: gene-therapy payloads for sub-retinal injection robots, which require [[Engineering/pharma-process-engineering]] cold-chain.

(Reprocessing details: [[Walkthroughs/design-surgical-robot-wrist]].)

15. Regulatory + safety

  • FDA — most lap-robot platforms cleared as Class II 510(k) (substantial equivalence to predicate); newer high-risk autonomous features may require De Novo or PMA. MMI Symani De Novo 2024, Medtronic Hugo US clearance 2024-25, THINK TMINI expanded indication Mar 2025, Edge Medical MP1000 NMPA 2023.
  • EU — MDR 2017/745 (in force since May 2021) with substantially stricter clinical-evidence + post-market requirements vs the legacy MDD. Notified-Body bottleneck has slowed CE renewal across the industry.
  • Quality system — ISO 13485 (QMS) + ISO 14971 (risk management) + IEC 60601-1 (general safety) + IEC 60601-2-77:2018 (specific to robotically-assisted surgical equipment) + IEC 62304 (medical SW lifecycle).
  • Cybersecurity — FDA 524B (Cybersecurity in Medical Devices, 2023 final) mandates SBOM + vulnerability disclosure + secure-update path for premarket submissions. EU NIS2 + IEC 81001-5-1.
  • AI/ML SaMD — FDA PCCP (Predetermined Change Control Plan) framework (2024 guidance) lets a manufacturer pre-declare model-update boundaries that won’t trigger a new submission.

16. Clinical evidence + cost

The cost narrative is the field’s enduring controversy:

  • Capital cost — da Vinci Xi ~USD 2.0-2.5 M, Series 5 priced similarly. Mako ~USD 1.0 M. Hugo + Versius positioned below Xi. SSi Mantra at ~USD 0.7-1.0 M.
  • Service contracts — ~USD 150-200k/yr.
  • Per-case incremental cost — ~USD 1,000-3,000 over laparoscopic baseline (instruments + capital amortization).

Outcome evidence is mixed:

  • Radical prostatectomy — clearest benefit (less blood loss, faster continence/potency recovery, equivalent oncologic outcomes). Robotic now standard-of-care in HIC.
  • Gynecology (hysterectomy, myomectomy) — comparable to laparoscopic; benefit when conventional laparoscopy is technically difficult.
  • Colorectal (low anterior, abdominoperineal) — emerging benefit on conversion rates and pelvic dissection precision; cost premium unclear.
  • General surgery (cholecystectomy, hernia) — comparable; cost-effectiveness contested.
  • Surgeon ergonomics — unambiguous benefit (no static loaded shoulder posture).

Learning curve — 20-100 cases to plateau depending on procedure and prior laparoscopic experience. Volume-outcome relationship strong: high-volume robotic centers outperform low-volume centers more than is the case in open surgery.

  • More autonomy + partial autonomy — task-level autonomy (knot-tying, anastomosis, suturing along a planned path) is now feasible (STAR); regulatory acceptance is the gate, not technology. FDA AI/ML PCCP is the pathway.
  • AI co-pilot — phase + anatomy + adverse-event detection from Proximie, Theator, Activ Surgical, Caresyntax becoming routine intra-op.
  • Single-port platforms — da Vinci SP indication expansion + Intuitive Forge concept (next-gen single-port platform sketched in 2024 investor day) + Distalmotion Dexter single-port mode.
  • Microsurgery + supermicrosurgery — sub-1 mm anastomosis (MMI Symani) opens lymphedema treatment + free-flap reconstruction + pediatric vascular access.
  • Genuinely flexible / soft robotic catheters — cardiovascular + GI; integration with [[Robotics/soft-robotics]].
  • Tele-surgery + 5G + remote training — Tianjin demos 2024-25, ongoing China + EU + India trials, military telemedicine interest.
  • Mass adoption in emerging markets — China (Edge Medical, Toumai, Microport Skywalker), India (SSi Mantra), Brazil, Russia indigenous systems at substantially lower price points.
  • Cost reduction + competition + consolidation — J&J/Auris/Verb merger 2025 → Ottava US lap-robot launch; Stryker + Smith+Nephew sports-medicine partnership; Medtronic Hugo expansion; Asensus → KARL STORZ 2024-25; Globus + NuVasive 2023; Orthofix + 7D → Renishaw 2024-25.

18. Pitfalls + risk

  • Port placement + arm collision — geometric planning is non-trivial; suboptimal trocar layout produces external arm collisions and lost dexterity.
  • Tactile loss — historical da Vinci issue; partially mitigated in Series 5 + competitors.
  • Long set-up + docking time — adds 15-30 min vs laparoscopic; workflow optimization is a major focus of newer platforms.
  • Cost + over-utilization — robotic-when-laparoscopic-would-do is a documented economic concern (Wright et al. JAMA Surg).
  • Cybersecurity — networked OR + connected platforms expand attack surface; FDA 524B mandates SBOM + disclosure.
  • Supply chain — instrument lifecycle counters + RFID create vendor lock-in; sterile-reprocessing variation across hospitals; cold-chain only matters for biologic payloads.
  • Regulatory delay — Notified-Body bottleneck under EU MDR; FDA backlog for complex AI/autonomy submissions.
  • Training curve + simulator availability — Mimic / Osso VR / SimNow / Touch Surgery cover most platforms but credentialing is institution-specific.

19. Cross-references

  • [[Walkthroughs/design-surgical-robot-wrist]] — instrument-wrist design walkthrough
  • [[Robotics/end-effectors]] — general end-effector overview
  • [[Robotics/Tier3/end-effectors-zoo]] — surgical-instrument deep dive
  • [[Robotics/teleoperation-haptics]] — bilateral teleop fundamentals
  • [[Robotics/Tier3/sensor-families]] — F/T + tactile sensing
  • [[Robotics/soft-robotics]] — flexible catheter + magnetic steering
  • [[Engineering/bioinstrumentation]] — sensor / electrosurgery / energy
  • [[Engineering/biomechanics]] — bone / soft-tissue mechanical context
  • [[Engineering/Tier3/stainless-steels]] — 316L / 17-4 PH for instruments
  • [[Engineering/Tier3/surface-treatments]] — TiN PVD coating for grippers
  • [[Engineering/pharma-process-engineering]] — gene / cell therapy delivery cold-chain
  • [[Compute/transformer-architecture]] — surgical foundation models
  • [[Biology/cell-molecular-biology]] — tissue mechanics + healing context
  • [[Biology/neuroscience-foundations]] (TBD) — neurosurgery context

20. Citations

  • Marescaux J. et al. (2001) “Transatlantic robot-assisted telesurgery,” Nature 413: 379-380 — Lindbergh Operation.
  • Hannaford B. (1992) — passive RCM mechanism analysis; Stoianovici D. (1998) — isocentric mechanism for image-guided surgery, IEEE Trans Robotics Automation.
  • Saeidi H. et al. (2022) “Autonomous robotic laparoscopic surgery for intestinal anastomosis,” Sci Robot 7(62): eabj2908 — STAR.
  • Intuitive Surgical 10-K Annual Report 2024 — procedure volume + installed base + Series 5 launch.
  • Medtronic Hugo RAS + Touch Surgery press releases 2024-25.
  • CMR Surgical Versius clinical-registry publications 2023-24.
  • FDA 510(k) and De Novo databases — Hugo (2024), Symani (2024), TMINI (Mar 2025), Yomi (2017), Mako, Mazor X, ExcelsiusGPS, Augmedics xVision, Ion, Monarch, CorPath GRX/Cor-Path.
  • China NMPA approval registry — Edge Medical MP1000 (2023), Toumai, Microport Skywalker.
  • CDSCO India — SSi Mantra (2022).
  • EU MDR 2017/745 + IEC 60601-2-77:2018 (Particular requirements for the basic safety and essential performance of robotically assisted surgical equipment) + IEC 81001-5-1 cybersecurity.
  • FDA Guidance: “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions” (2023) — Section 524B; “Marketing Submission Recommendations for a Predetermined Change Control Plan for AI/ML-Enabled Device Software Functions” (2024).
  • J&J MedTech Auris acquisition disclosures (2019); Verb Surgical → Ottava platform updates 2024-25.
  • Stryker Mako 2024 10-K + investor presentations.
  • Globus Medical / NuVasive 2023 merger filings.
  • Brainlab Cirq + Globus ExcelsiusGPS + Medtronic Mazor X 2024 product brochures.
  • Neocis Yomi 510(k) and 2024 clinical-use statistics.
  • Theator + Activ Surgical + Caresyntax + Proximie product overviews + 2024 clinical-evidence publications.
  • Chen A.C. et al. (2024) “Robotic bronchoscopy diagnostic yield for peripheral pulmonary lesions: PRECIsE / BENEFIT registries.”
  • Stereotaxis Genesis RMN + MAGIC catheter 2024-25 CE / FDA filings.
  • Preceyes Surgical System (Zeiss) sub-retinal gene-therapy delivery clinical reports 2024.

Graph View